ZA959729B - Immunogenic compositions - Google Patents
Immunogenic compositionsInfo
- Publication number
- ZA959729B ZA959729B ZA959729A ZA959729A ZA959729B ZA 959729 B ZA959729 B ZA 959729B ZA 959729 A ZA959729 A ZA 959729A ZA 959729 A ZA959729 A ZA 959729A ZA 959729 B ZA959729 B ZA 959729B
- Authority
- ZA
- South Africa
- Prior art keywords
- immunogenic compositions
- immunogenic composition
- solubilised
- immunogen
- absence
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 229940126578 oral vaccine Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9422990A GB9422990D0 (en) | 1994-11-15 | 1994-11-15 | Immunogenic compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA959729B true ZA959729B (en) | 1997-05-15 |
Family
ID=10764393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA959729A ZA959729B (en) | 1994-11-15 | 1995-11-15 | Immunogenic compositions |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0792165B1 (xx) |
JP (1) | JP4297515B2 (xx) |
KR (1) | KR970706848A (xx) |
CN (1) | CN100346828C (xx) |
AT (1) | ATE249841T1 (xx) |
AU (1) | AU700910B2 (xx) |
CA (1) | CA2205083A1 (xx) |
DE (1) | DE69531793T2 (xx) |
DK (1) | DK0792165T3 (xx) |
ES (1) | ES2210318T3 (xx) |
FI (1) | FI972054A (xx) |
GB (1) | GB9422990D0 (xx) |
IL (1) | IL116010A0 (xx) |
MX (1) | MX9703480A (xx) |
NO (1) | NO972219L (xx) |
NZ (1) | NZ295238A (xx) |
PT (1) | PT792165E (xx) |
WO (1) | WO1996014871A1 (xx) |
ZA (1) | ZA959729B (xx) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9323588D0 (en) | 1993-11-16 | 1994-01-05 | Cortecs Ltd | Hydrophobic preparation |
US6165773A (en) * | 1995-10-25 | 2000-12-26 | Provalis Uk Limited | Methods of preserving viruses |
GB9613858D0 (en) | 1996-07-02 | 1996-09-04 | Cortecs Ltd | Hydrophobic preparations |
AU736038C (en) * | 1997-07-10 | 2006-08-10 | Intervet Australia Pty Limited | Non-aqueous vaccines |
UY25089A1 (es) * | 1997-07-10 | 2000-08-21 | Hoechst Roussel Vet Gmbh | Vacunas no acuosas |
KR100585408B1 (ko) * | 1998-02-12 | 2006-06-01 | 와이어쓰 홀딩스 코포레이션 | 인터루킨-12로 제형된 폐렴구균 및 수막구균 백신 |
CN1224422C (zh) * | 1998-02-12 | 2005-10-26 | 惠氏控股有限公司 | 含有白细胞介素il-12和单纯疱疹病毒抗原的疫苗 |
CA2320042A1 (en) * | 1998-02-12 | 1999-08-19 | American Cyanamid Company | Vaccines comprising interleukin-12 and respiratory syncytial viral antigens |
ES2296390T3 (es) * | 1998-05-07 | 2008-04-16 | Corixa Corporation | Composicion coadyuvante y procedimiento para su uso. |
EP1097715A4 (en) * | 1998-07-16 | 2004-12-29 | Hayashi Akira | PREPARATIONS FOR ANTICANCER IMMUNOTHERAPY COMPRISING A BACTERIAL SOMATIC COMPONENT AS AN ACTIVE INGREDIENT |
CN101827613A (zh) | 2007-09-27 | 2010-09-08 | 免疫疫苗技术有限公司 | 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用 |
JP5591705B2 (ja) * | 2007-10-03 | 2014-09-17 | イムノバクシーン・テクノロジーズ・インコーポレイテッド | 抗原、両親媒性化合物及び疎水性担体を含有する組成物、並びにその使用 |
CA2723918C (en) | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
CN103517714A (zh) * | 2010-12-23 | 2014-01-15 | 英珀特疗法有限公司 | 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物 |
GB201107629D0 (en) * | 2011-05-06 | 2011-06-22 | Proxima Concepts Ltd | Hydrophobic preparations |
CN102277373B (zh) * | 2011-08-15 | 2014-07-02 | 南京大学 | 一种减毒沙门氏菌分泌表达的日本血吸虫疫苗表达载体及其应用 |
EP2763698B1 (en) | 2011-10-06 | 2020-12-02 | ImmunoVaccine Technologies Inc. | Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4578391A (en) * | 1982-01-20 | 1986-03-25 | Yamanouchi Pharmaceutical Co., Ltd. | Oily compositions of antitumor drugs |
IE904098A1 (en) * | 1989-11-13 | 1991-05-22 | Nova Pharm Corp | Lipospheres for controlled delivery of substances |
ES2193134T3 (es) * | 1991-06-26 | 2003-11-01 | Yamanouchi Europ Bv | Procedimiento para la preparacion de dispersiones de vesiculas encapsuladas. |
ATE179599T1 (de) * | 1993-08-06 | 1999-05-15 | Opperbas Holding Bv | Verfahren zur hohen beladung von vesikeln mit biopolymeren substanzen |
GB9323588D0 (en) * | 1993-11-16 | 1994-01-05 | Cortecs Ltd | Hydrophobic preparation |
-
1994
- 1994-11-15 GB GB9422990A patent/GB9422990D0/en active Pending
-
1995
- 1995-11-14 DK DK95936690T patent/DK0792165T3/da active
- 1995-11-14 ES ES95936690T patent/ES2210318T3/es not_active Expired - Lifetime
- 1995-11-14 CA CA002205083A patent/CA2205083A1/en not_active Abandoned
- 1995-11-14 PT PT95936690T patent/PT792165E/pt unknown
- 1995-11-14 KR KR1019970703089A patent/KR970706848A/ko not_active Application Discontinuation
- 1995-11-14 JP JP51584796A patent/JP4297515B2/ja not_active Expired - Fee Related
- 1995-11-14 AU AU38534/95A patent/AU700910B2/en not_active Ceased
- 1995-11-14 MX MX9703480A patent/MX9703480A/es unknown
- 1995-11-14 AT AT95936690T patent/ATE249841T1/de not_active IP Right Cessation
- 1995-11-14 CN CNB951962590A patent/CN100346828C/zh not_active Expired - Fee Related
- 1995-11-14 EP EP95936690A patent/EP0792165B1/en not_active Expired - Lifetime
- 1995-11-14 NZ NZ295238A patent/NZ295238A/xx unknown
- 1995-11-14 DE DE69531793T patent/DE69531793T2/de not_active Expired - Lifetime
- 1995-11-14 WO PCT/GB1995/002675 patent/WO1996014871A1/en active Search and Examination
- 1995-11-15 IL IL11601095A patent/IL116010A0/xx unknown
- 1995-11-15 ZA ZA959729A patent/ZA959729B/xx unknown
-
1997
- 1997-05-14 NO NO972219A patent/NO972219L/no not_active Application Discontinuation
- 1997-05-14 FI FI972054A patent/FI972054A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
FI972054A0 (fi) | 1997-05-14 |
AU700910B2 (en) | 1999-01-14 |
KR970706848A (ko) | 1997-12-01 |
ES2210318T3 (es) | 2004-07-01 |
EP0792165A1 (en) | 1997-09-03 |
JP4297515B2 (ja) | 2009-07-15 |
GB9422990D0 (en) | 1995-01-04 |
DK0792165T3 (da) | 2004-01-05 |
CN1163575A (zh) | 1997-10-29 |
MX9703480A (es) | 1997-08-30 |
NO972219L (no) | 1997-07-11 |
NZ295238A (en) | 1999-01-28 |
CA2205083A1 (en) | 1996-05-23 |
WO1996014871A1 (en) | 1996-05-23 |
FI972054A (fi) | 1997-05-14 |
CN100346828C (zh) | 2007-11-07 |
EP0792165B1 (en) | 2003-09-17 |
JPH10508834A (ja) | 1998-09-02 |
AU3853495A (en) | 1996-06-06 |
DE69531793T2 (de) | 2004-07-15 |
NO972219D0 (no) | 1997-05-14 |
DE69531793D1 (de) | 2003-10-23 |
ATE249841T1 (de) | 2003-10-15 |
PT792165E (pt) | 2004-02-27 |
IL116010A0 (en) | 1996-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL116010A0 (en) | Immunogenic compositions | |
WO1997001640A3 (en) | Vaccines against hepatitis c | |
GR3025184T3 (en) | Vaccine composition containing adjuvants. | |
IL89503A0 (en) | Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof | |
AU2982889A (en) | Novel dosage form of fenofibrate | |
CA2217178A1 (en) | Vaccines containing a saponin and a sterol | |
AU4867697A (en) | Oxadiazoles, processes for preparing them and their use as pharmaceutical compositions | |
AU7546887A (en) | Variants of lav viruses, their dna- and protein-components and their uses, particularly for diagnostic purposes and for the preparation of immunogenic compositions | |
AU6913687A (en) | Solid antitartar mouth deodorant composition | |
CA2177668A1 (en) | Mammalian vaccine compositions comprising squalene or squalane, glycerol and a surfactant as an adjuvant | |
AU4622693A (en) | Potentiation of immunogenic response | |
DZ2283A1 (fr) | Composition de vaccin. | |
EP1891968A3 (en) | Rotavirus vaccine formulations | |
IL98262A0 (en) | Chromone derivatives and pharmaceutical compositions containing them | |
WO1997005899A3 (en) | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same | |
CA2068431A1 (en) | Stabilized stannous fluoride compositions for oral care | |
CA2216410A1 (en) | Improved inactivated vaccines | |
CA2063273A1 (en) | Surfactant compositions and methods | |
NZ239281A (en) | Antigenic hiv conjugate, vaccine and pharmaceutical composition | |
AU4450696A (en) | Enhanced immunogenic vaccine | |
AU8204887A (en) | Conjugate vaccine | |
HUP9903649A3 (en) | Taxane derivatives, the preparation thereof and medical formulations containing them | |
AU2901997A (en) | Immunogenic complex, use, method of preparation thereof and vaccine containing same | |
AU7528087A (en) | Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it | |
EG20082A (en) | Process for preparing of octadecyl-(2-N-methylpiperidino)-ethyl-phosphate |